Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
US Army
Cantor Fitzgerald
Cipla
Covington
Novartis
Johnson and Johnson
Chubb
McKesson
Medtronic

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,866,839

« Back to Dashboard

Summary for Patent: 6,866,839
Title: Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
Abstract:A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
Inventor(s): Aberg; Gunnar (Westborough, MA), Morley; John (Richmond-upon-Thames, GB)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:10/457,123
Patent Claim Types:
see list of patent claims
Use; Dosage form; Delivery; Composition;

Drugs Protected by US Patent 6,866,839

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,866,839

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9107196Apr 05, 1991

International Patents Family Members for US Patent 6,866,839

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 9107196 ➤ Subscribe
United Kingdom 2289842 ➤ Subscribe
United Kingdom 2255503 ➤ Subscribe
United Kingdom 9517463 ➤ Subscribe
France 2674751 ➤ Subscribe
United Kingdom 9207363 ➤ Subscribe
Canada 2065051 ➤ Subscribe
Italy RM920237 ➤ Subscribe
Switzerland 685672 ➤ Subscribe
Switzerland 686869 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
McKinsey
Deloitte
Cerilliant
Cantor Fitzgerald
US Army
UBS
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot